Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 326 publications
Cholangiocarcinoma - Morphology, Immunohistochemistry, and Genetics.
Journal: Ceskoslovenska patologie
Published: October 16, 2025
Recent insights and clinical issues in acute myeloid leukemia in older adults
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: October 01, 2025
Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutations.
Journal: medRxiv : the preprint server for health sciences
Published: August 08, 2025
Updates on Therapy Options in Fit and Unfit Patients with Newly Diagnosed AML.
Journal: Current treatment options in oncology
Published: July 30, 2025
Safety and efficacy of ivosidenib in the treatment of isocitrate dehydrogenase 1 mutant cholangiocarcinoma and acute myeloid leukemia: a systematic review and meta-analysis.
Journal: Anti-cancer drugs
Published: July 23, 2025
Targeting of Mutant Isocitrate Dehydrogenase in Glioma: A Systematic Review.
Journal: Cancers
Published: July 11, 2025
Deep Dive into Targeted Therapies: Understanding IDH1-Mutant AML Treatments [Podcast].
Journal: Blood and lymphatic cancer : targets and therapy
Published: June 26, 2025
Effect of the IDH1 inhibitor combined with hypomethylating agents on acute myeloid leukemia.
Journal: Tumori
Published: June 20, 2025
Advancing AML Treatment: Evidence-Based Regimens and Guideline Updates for Targeted Treatments in R/R AML [Podcast].
Journal: Blood and lymphatic cancer : targets and therapy
Published: June 19, 2025
Outcomes of Frontline Triplet Regimens With a Hypomethylating Agent, Venetoclax, and Isocitrate Dehydrogenase Inhibitor for Intensive Chemotherapy-Ineligible Patients With Isocitrate Dehydrogenase-Mutated AML.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 13, 2025
Effectiveness of olutasidenib versus ivosidenib in patients with mutated isocitrate dehydrogenase 1 acute myeloid leukemia who are relapsed or refractory to venetoclax: the 2102-HEM-101 trial versus a US electronic health record-based external control arm.
Journal: Leukemia & lymphoma
Published: June 13, 2025
Indirect treatment comparison of ivosidenib and other therapies in patients with newly diagnosed acute myeloid leukemia.
Journal: Future oncology (London, England)
Published: June 10, 2025
Last Updated: 10/31/2025